Literature DB >> 11095772

Fungal Infections of the Lung.

.   

Abstract

Fungi, both endemic and opportunistic, continue to be recognized as increasingly frequent pulmonary pathogens. Better appreciation of their epidemiology and clinical course, as well as clarification of the roles of the newer triazoles and lipid formulations of amphotericin B in treatment, have occurred within the past few years. Both endemic and opportunistic fungal pulmonary pathogens are reviewed, with emphasis on recent therapeutic advances.

Entities:  

Year:  1999        PMID: 11095772      PMCID: PMC7102184          DOI: 10.1007/s11908-999-0015-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  91 in total

1.  Pulmonary blastomycosis with acute respiratory failure as predominant clinical feature.

Authors:  R Mukkamala; J B Mehta; J W Myers; C P Cole
Journal:  South Med J       Date:  1997-08       Impact factor: 0.954

2.  Immunologic, genetic and social human risk factors associated to histoplasmosis: studies in the State of Guerrero, Mexico.

Authors:  M L Taylor; A Pérez-Mejía; J K Yamamoto-Furusho; J Granados
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

3.  Efficacy of nikkomycin Z against experimental pulmonary blastomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

Authors:  D A Stevens; J Y Lee
Journal:  Arch Intern Med       Date:  1997-09-08

5.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Coccidioidomycosis in liver transplant patients.

Authors:  C D Holt; D J Winston; B Kubak; D K Imagawa; P Martin; L Goldstein; K Olthoff; J M Millis; A Shaked; C R Shackleton; R W Busuttil
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

8.  Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors.

Authors:  F Visnegarwala; E A Graviss; C E Lacke; A T Dural; P C Johnson; R L Atmar; R J Hamill
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

Review 9.  Histoplasmosis: recognition and treatment.

Authors:  J Wheat
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

10.  Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Authors:  T J Walsh; J W Hiemenz; N L Seibel; J R Perfect; G Horwith; L Lee; J L Silber; M J DiNubile; A Reboli; E Bow; J Lister; E J Anaissie
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.